Charles Schwab’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$58.8M Buy
1,487,818
+44,189
+3% +$1.75M 0.01% 1000
2025
Q1
$43.6M Sell
1,443,629
-37,811
-3% -$1.14M 0.01% 1169
2024
Q4
$51.8M Buy
1,481,440
+38,420
+3% +$1.34M 0.01% 1108
2024
Q3
$57.8M Buy
1,443,020
+114,914
+9% +$4.6M 0.01% 1025
2024
Q2
$63.3M Buy
1,328,106
+26,738
+2% +$1.27M 0.01% 897
2024
Q1
$56.4M Buy
1,301,368
+26,049
+2% +$1.13M 0.01% 955
2023
Q4
$64.5M Buy
1,275,319
+33,012
+3% +$1.67M 0.02% 801
2023
Q3
$56.4M Buy
1,242,307
+43,087
+4% +$1.95M 0.02% 802
2023
Q2
$49.2M Buy
1,199,220
+12,827
+1% +$526K 0.01% 870
2023
Q1
$42.4M Sell
1,186,393
-69,875
-6% -$2.5M 0.01% 950
2022
Q4
$47.4M Buy
1,256,268
+53,922
+4% +$2.04M 0.02% 855
2022
Q3
$53.2M Buy
1,202,346
+48,321
+4% +$2.14M 0.02% 719
2022
Q2
$42.7M Buy
1,154,025
+16,198
+1% +$600K 0.01% 849
2022
Q1
$42.1M Buy
1,137,827
+44,388
+4% +$1.64M 0.01% 985
2021
Q4
$33.3M Buy
1,093,439
+23,707
+2% +$721K 0.01% 1193
2021
Q3
$35.9M Buy
1,069,732
+355,772
+50% +$11.9M 0.01% 1092
2021
Q2
$28.5M Buy
713,960
+17,464
+3% +$697K 0.01% 1291
2021
Q1
$31.3M Buy
696,496
+5,087
+0.7% +$229K 0.01% 1157
2020
Q4
$39.1M Buy
691,409
+10,205
+1% +$577K 0.02% 936
2020
Q3
$32.3M Buy
681,204
+64,735
+11% +$3.07M 0.01% 905
2020
Q2
$36.3M Buy
616,469
+5,770
+0.9% +$340K 0.02% 772
2020
Q1
$28.9M Buy
610,699
+13,474
+2% +$637K 0.02% 767
2019
Q4
$36.1M Buy
597,225
+9,126
+2% +$551K 0.02% 827
2019
Q3
$35.2M Sell
588,099
-28,414
-5% -$1.7M 0.02% 786
2019
Q2
$39.6M Buy
616,513
+33,997
+6% +$2.19M 0.02% 690
2019
Q1
$47.3M Buy
582,516
+37,679
+7% +$3.06M 0.03% 568
2018
Q4
$29.5M Buy
544,837
+19,082
+4% +$1.03M 0.02% 730
2018
Q3
$27.1M Buy
525,755
+71,526
+16% +$3.69M 0.02% 939
2018
Q2
$18.9M Buy
454,229
+27,355
+6% +$1.14M 0.01% 1130
2018
Q1
$18.8M Buy
426,874
+24,894
+6% +$1.1M 0.01% 1046
2017
Q4
$20.2M Buy
401,980
+20,246
+5% +$1.02M 0.02% 972
2017
Q3
$19.4M Buy
381,734
+14,184
+4% +$719K 0.02% 950
2017
Q2
$18.7M Buy
367,550
+54,587
+17% +$2.78M 0.02% 895
2017
Q1
$12.6M Buy
312,963
+3,688
+1% +$148K 0.01% 1144
2016
Q4
$14.8M Buy
309,275
+39,145
+14% +$1.87M 0.02% 967
2016
Q3
$9.9M Buy
270,130
+62,194
+30% +$2.28M 0.01% 1170
2016
Q2
$4.84M Sell
207,936
-52,929
-20% -$1.23M 0.01% 1577
2016
Q1
$10.6M Buy
260,865
+4,895
+2% +$198K 0.01% 1014
2015
Q4
$15.9M Buy
255,970
+21,139
+9% +$1.31M 0.02% 712
2015
Q3
$9.49M Buy
234,831
+16,946
+8% +$685K 0.01% 1031
2015
Q2
$12.5M Sell
217,885
-161,645
-43% -$9.3M 0.02% 865
2015
Q1
$24.2M Buy
379,530
+20,294
+6% +$1.29M 0.03% 489
2014
Q4
$22.2M Buy
359,236
+9,077
+3% +$560K 0.03% 493
2014
Q3
$13.6M Buy
350,159
+5,700
+2% +$221K 0.02% 629
2014
Q2
$11.9M Buy
344,459
+3,282
+1% +$113K 0.02% 699
2014
Q1
$14.7M Sell
341,177
-12,685
-4% -$548K 0.03% 571
2013
Q4
$14.1M Buy
353,862
+64,821
+22% +$2.58M 0.03% 543
2013
Q3
$11M Sell
289,041
-122,559
-30% -$4.65M 0.02% 599
2013
Q2
$11.7M Buy
+411,600
New +$11.7M 0.03% 514